Skip to main content
OpenTrials

Clinical trial condition

Lung Neuroendocrine Neoplasm

Explore clinical trials studying Lung Neuroendocrine Neoplasm. Study availability and eligibility vary by location and protocol.

9 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Lung Neuroendocrine Neoplasm trial results

Recruiting

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

NCT04665739

Conditions
Advanced Lung Neuroendocrine Tumor, Functioning Lung Neuroendocrine Tumor, Locally Advanced Lung Neuroendocrine Neoplasm, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 29 locations
View Trial Details
Recruiting

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

NCT05918302

Conditions
Hemic and Lymphatic Diseases, Lung Neuroendocrine Neoplasm, Lymphatic Diseases, +9 more
Locations
  • Antwerp University Hospital (UZA) Edegem, Belgium
  • UCL Saint-Luc Brussels, Belgium
  • CHU Liège Liège, Belgium
  • Hospital Center University Dijon Bourgogne (CHU Bourgogne) Dijon, France
View all 27 locations
View Trial Details
Active, Not Recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

NCT03600233

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations
  • Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Active, Not Recruiting

Neuroendocrine Tumors - Patient Reported Outcomes

NCT05064150

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Research Institute, Inc Kansas City, Kansas, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details

Related conditions